Nanopoint, Inc, is a biophotonics company specializing in the development of ultra-high resolution intracellular imaging products. Nanopoint enables non-destructive continuous imaging of three dimensional objects and processes within living cells, at resolutions starting at 50 nanometers. Applications range from drug discovery and development, to the early identification of cancer disease states. The early-stage, proof-of-concept research was funded through grants from the National Science Foundation (NSF), in collaboration with world-class researchers at Stanford University, University of Hawaii, and University of Arizona.
Names, and logos of other organizations are the property of those organizations and not of NSTI.
This event is not open to the general public and NSTI reserves the right to refuse admission and participation to any individual.
